Comparative risks of non-prescription analgesics: a structured topic review and research priorities

Bibliography

• Mitchell AA, Kaufman DW, Rosenbery L. Patterns of medication use in the United States, 2006: a report from the Slone Survey. Slone Epidemiology Center at Boston University; Boston, MA: 2007
   Google Scholar
• US Census Bureau. 2006 - 2008 American Community Survey 3-Year Estimates. Washington DC: 2009
   Google Scholar
• Ganley C, Johnson S, Osborne S, Recommendations for FDA Interventions toDecrease the Occurrence of Acetaminophen Hepatotoxicity, 2008
   Google Scholar
• Centers for Disease Control and Prevenetion. Compressed Mortality File 1999-2007. CDC WONDER On-line Database. 20 No. 2M ed, 2007
   Google Scholar
• Heard KJ, Ries NL, Dart RC, Overuse of non-prescription analgesics by dental clinic patients. BMC Oral Health 2008;8:33
   PubMedGoogle Scholar
• Heard K, Sloss D, Weber S, Overuse of over-the-counter analgesics by emergency department patients. Ann Emerg Med 2006;48:315-18
   PubMed Web of Science ®Google Scholar
• Wilcox CM, Cryer B, Triadafilopoulos G. Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs. J Rheumatol 2005;32:2218-24
   PubMed Web of Science ®Google Scholar
• Bronstein AC, Spyker DA, Cantilena LR Jr, 2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report. Clin Toxicol 2010;48:979-1178
   PubMed Web of Science ®Google Scholar
• Stratton K, Almario DA, Wizemann TM, Immunization Safety Review: Vaccination and Sudden Unexpected Death in Infancy. Insitute of Medicine of the National Academies; Washington DC: 2003
   Google Scholar
• GRADE working group, 2010
   Google Scholar
• Guyatt GH, Oxman AD, Kunz R, What is "quality of evidence" and why is it important to clinicians? BMJ 2008;336:995-8
   PubMed Web of Science ®Google Scholar
• Spangler DL. Advancing understanding for safe suse of acetaminophen: consumer knowledge (Rx and OTC). Presentation to the American Pain Foundation; 10 November 2010; Bethesda, MD
   Google Scholar
• Qato DM, Alexander GC, Conti RM, Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008;300:2867-78
   PubMed Web of Science ®Google Scholar
• Fries JF, Bruce B. Rates of serious gastrointestinal events from low dose use of acetylsalicylic acid, acetaminophen, and ibuprofen in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol 2003;30:2226-33
   PubMed Web of Science ®Google Scholar
• Ganley CJ, Paget SA, Reidenberg MM. Increased renal tubular cell excretion by patients receiving chronic therapy with gold and with nonsteroidal anti-inflammatory drugs. Clin Pharmacol Ther 1989;46:51-5
   PubMed Web of Science ®Google Scholar
• Gislason GH, Rasmussen JN, Abildstrom SZ, Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med 2009;169:141-9
   PubMed Web of Science ®Google Scholar
• National Institutes of Health - National Heart, Lung, and Blood Institute. Morbidity & Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: 2009
   Google Scholar
• NSAID Focus. Bandolier Journal 1998;5:2-6
   Google Scholar
• Zhang WY, Li Wan Po A. Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review. Br J Obstet Gynaecol 1998;105:780-9
   PubMedGoogle Scholar
• Milsom I, Minic M, Dawood MY, Comparison of the efficacy and safety of nonprescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrhea: a pooled analysis of five studies. Clin Ther 2002;24:1384-400
   PubMed Web of Science ®Google Scholar
• Towheed TE, Maxwell L, Judd MG, Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006;CD004257
   PubMed Web of Science ®Google Scholar
• Wienecke T, Gotzsche PC. Paracetamol versus nonsteroidal anti-inflammatory drugs for rheumatoid arthritis. Cochrane Database Syst Rev 2004;CD003789
   Google Scholar
• McNicol E, Strassels SA, Goudas L, NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database Syst Rev 2005
   Web of Science ®Google Scholar
• Pierce CA, Voss B. Efficacy and safety of ibuprofen and acetaminophen in children and adults: a meta-analysis and qualitative review. Ann Pharmacother 2010;44:489-506
   PubMed Web of Science ®Google Scholar
• Solomon DH, Rassen JA, Glynn RJ, The comparative safety of analgesics in older adults with arthritis. Arch Intern Med 2010;170:1968-76
   PubMed Web of Science ®Google Scholar
• Moore N, Van Ganse E, Le Parc JM, The PAIN study: Paracetamol, aspirin and ibuprofen new tolerability study. A large-scale, randomised clinical trial comparing the tolerability of aspirin, ibuprofen and paracetamol for short-term analgesia. Clin Drug Investig 1999;18:89-98
   Web of Science ®Google Scholar
• Moore N, Charlesworth A, Van Ganse E, Risk factors for adverse events in analgesic drug users: results from the PAIN study. Pharmacoepidemiol Drug Saf 2003;12:601-10
   PubMed Web of Science ®Google Scholar
• Moore N. Forty years of ibuprofen use. Int J Clin Pract Suppl 2003;28-31
   PubMedGoogle Scholar
• Van Ganse E, Jones JK, Moore N, A large simple clinical trial prototype for assessment of OTC drug effects using patient-reported data. Pharmacoepidemiol Drug Saf 2005;14:249-55
   PubMed Web of Science ®Google Scholar
• Bandolier Journal. Oxford league table of analgesics in acute pain, 2007
   Google Scholar
• Trelle S, Reichenbach S, Wandel S, Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011;342:c7086
   PubMed Web of Science ®Google Scholar
• Steiner TJ, Voelker M. Gastrointestinal tolerability of aspirin and the choice of over-the-counter analgesia for short-lasting acute pain. J Clin Pharm Ther 2009;34:177-86
   PubMed Web of Science ®Google Scholar
• Hernandez-Diaz S, Varas-Lorenzo C, Garcia Rodriguez LA. Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction. Basic Clin Pharmacol Toxicol 2006;98:266-74
   PubMed Web of Science ®Google Scholar
• Fosbol EL, Folke F, Jacobsen S, Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals. Circ Cardiovasc Qual Outcomes 2010;3:395-405
   PubMed Web of Science ®Google Scholar
• Sandler DP, Smith JC, Weinberg CR, Analgesic use and chronic renal disease. N Engl J Med 1989;320:1238-43
   PubMed Web of Science ®Google Scholar
• Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 1994;331:1675-9
   PubMed Web of Science ®Google Scholar
• Fored CM, Ejerblad E, Lindblad P, Acetaminophen, aspirin, and chronic renal failure. N Engl J Med 2001;345:1801-8
   PubMed Web of Science ®Google Scholar
• Curhan GC, Knight EL, Rosner B, Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med 2004;164:1519-24
   PubMed Web of Science ®Google Scholar
• Bradley JD, Brandt KD, Katz BP, Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991;325:87-91
   PubMed Web of Science ®Google Scholar
• Kuffner EK, Dart RC, Bogdan GM, Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 2001;161:2247-52
   PubMed Web of Science ®Google Scholar
• Pincus T, Koch GG, Sokka T, A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum 2001;44:1587-98
   PubMed Web of Science ®Google Scholar
• Kuffner EK, Temple AR, Cooper KM, Retrospective analysis of transient elevations in alanine aminotransferase during long-term treatment with acetaminophen in osteoarthritis clinical trials. Curr Med Res Opin 2006;22:2137-48
   PubMed Web of Science ®Google Scholar
• Temple AR, Benson GD, Zinsenheim JR, Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis. Clin Ther 2006;28:222-35
   PubMed Web of Science ®Google Scholar
• Watkins PB, Kaplowitz N, Slattery JT, Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006;296:87-93
   PubMed Web of Science ®Google Scholar
• Heard K, Green JL, Bailey JE, A randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcohol. Aliment Pharmacol Ther 2007;26:283-90
   PubMed Web of Science ®Google Scholar
• Kuffner EK, Green JL, Bogdan GM, The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients--a multicenter randomized study. BMC Med 2007;5:13
   PubMed Web of Science ®Google Scholar
• Bartels S, Sivilotti M, Crosby D, Are recommended doses of acetaminophen hepatotoxic for recently abstinent alcoholics? A randomized trial. Clin Toxicol 2008;46:243-9
   PubMed Web of Science ®Google Scholar
• Heard KJ, Green JL, Dart RC. Serum alanine aminotransferase elevation during 10 days of acetaminophen use in nondrinkers. Pharmacotherapy 2010;30:818-22
   PubMed Web of Science ®Google Scholar
• Dart RC, Green JL, Kuffner EK, The effects of paracetamol (acetaminophen) on hepatic tests in patients who chronically abuse alcohol - a randomized study. Aliment Pharmacol Ther 2010;32:478-86
   PubMed Web of Science ®Google Scholar
• Shaheen SO, Sterne JA, Songhurst CE, Frequent paracetamol use and asthma in adults. Thorax 2000;55:266-70
   PubMed Web of Science ®Google Scholar
• Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004;328:434
   PubMed Web of Science ®Google Scholar
• Menzies D, Nair A, Meldrum KT, Effect of aspirin on airway inflammation and pulmonary function in patients with persistent asthma. J Allergy Clin Immunol 2008;121:1184-9
   PubMed Web of Science ®Google Scholar
• Henry D, Lim LL, Garcia Rodriguez LA, Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996;312:1563-6
   PubMed Web of Science ®Google Scholar
• Blot WJ, McLaughlin JK. Over the counter non-steroidal anti-inflammatory drugs and risk of gastrointestinal bleeding. J Epidemiol Biostatistics 2000;5:137-42
   PubMedGoogle Scholar
• Lanas A, Serrano P, Bajador E, Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs. Eur J Gastroenterol Hepatol 2003;15:173-8
   PubMed Web of Science ®Google Scholar
• Berger JS, Roncaglioni MC, Avanzini F, Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006;295:306-13
   PubMed Web of Science ®Google Scholar
• Werler MM, Bosco JL, Shapira SK. Maternal vasoactive exposures, amniotic bands, and terminal transverse limb defects. Birth Defects Res 2009;85:52-7
   PubMed Web of Science ®Google Scholar
• Morgan GJ, Poland M, DeLapp RE. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly. Am J Med 1993;95:19S-27S
   PubMedGoogle Scholar
• Evans JM, McGregor E, McMahon AD, Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure. QJM 1995;88:551-7
   PubMed Web of Science ®Google Scholar
• Perez Gutthann S, Garcia Rodriguez LA, Raiford DS, Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Arch Intern Med 1996;156:2433-9
   PubMed Web of Science ®Google Scholar
• Griffin MR, Yared A, Ray WA. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol 2000;151:488-96
   PubMed Web of Science ®Google Scholar
• Clinard F, Sgro C, Bardou M, Association between concomitant use of several systemic NSAIDs and an excess risk of adverse drug reaction. A case/non-case study from the French Pharmacovigilance system database. Eur J Clin Pharmacol 2004;60:279-83
   PubMed Web of Science ®Google Scholar
• Horackova M, Charvat J, Hasa J, Life-threatening renal failure caused by vasomotor nephropathy associated with nonsteroidal anti-inflammatory drugs. Int J Clin Pharmacol Res 2004;24:117-22
   PubMedGoogle Scholar
• Huerta C, Castellsague J, Varas-Lorenzo C, Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis 2005;45:531-9
   PubMed Web of Science ®Google Scholar
• Ibanez L, Morlans M, Vidal X, Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease. Kidney Int 2005;67:2393-8
   PubMed Web of Science ®Google Scholar
• Schneider V, Levesque LE, Zhang B, Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis. Am J Epidemiol 2006;164:881-9
   PubMed Web of Science ®Google Scholar
• Kurth T, Glynn RJ, Walker AM, Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation 2003;108:1191-5
   PubMed Web of Science ®Google Scholar
• Mamdani M, Rochon P, Juurlink DN, Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly. Arch Intern Med 2003;163:481-6
   PubMed Web of Science ®Google Scholar
• Lipworth L, Friis S, Blot WJ, A population-based cohort study of mortality among users of ibuprofen in Denmark. Am J Ther 2004;11:156-63
   PubMedGoogle Scholar
• Fischer LM, Schlienger RG, Matter CM, Current use of nonsteroidal antiinflammatory drugs and the risk of acute myocardial infarction. Pharmacotherapy 2005;25:503-10
   PubMed Web of Science ®Google Scholar
• Garcia Rodriguez LA, Gonzalez-Perez A. Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. BMC Med 2005;3:17
   PubMed Web of Science ®Google Scholar
• Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005;330:1366
   PubMed Web of Science ®Google Scholar
• Johnsen SP, Larsson H, Tarone RE, Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Arch Int Med 2005;165:978-84
   PubMed Web of Science ®Google Scholar
• Gislason GH, Jacobsen S, Rasmussen JN, Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Circulation 2006;113:2906-13
   PubMed Web of Science ®Google Scholar
• Hawkey CJ, Hawkey GM, Everitt S, Increased risk of myocardial infarction as first manifestation of ischaemic heart disease and nonselective nonsteroidal anti-inflammatory drugs. Br J Clin Pharmacol 2006;61:730-7
   PubMed Web of Science ®Google Scholar
• Helin-Salmivaara A, Virtanen A, Idanpaan-Heikkila JE, NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland. Eur Heart J 2006;27:1657-63
   PubMed Web of Science ®Google Scholar
• Jick H, Kaye JA, Russmann S, Nonsteroidal antiinflammatory drugs and acute myocardial infarction in patients with no major risk factors. Pharmacotherapy 2006;26:1379-87
   PubMed Web of Science ®Google Scholar
• Solomon DH, Avorn J, Sturmer T, Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum 2006;54:1378-89
   PubMed Web of Science ®Google Scholar
• Garcia Rodriguez LA, Egan K, FitzGerald GA. Traditional nonsteroidal anti-inflammatory drugs and postmenopausal hormone therapy: a drug-drug interaction? PLoS Med 2007;4:e157
   PubMedGoogle Scholar
• Lee TA, Bartle B, Weiss KB. Impact of NSAIDS on mortality and the effect of preexisting coronary artery disease in US veterans. Am J Med 2007;120:98- e9-16
   PubMedGoogle Scholar
• Garcia Rodriguez LA, Tacconelli S, Patrignani P. Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population. J Am Coll Cardiol 2008;52:1628-36
   PubMed Web of Science ®Google Scholar
• van Staa TP, Rietbrock S, Setakis E, Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction? J Intern Med 2008;264:481-92
   PubMed Web of Science ®Google Scholar
• Solomon DH, Glynn RJ, Rothman KJ, Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups. Arthritis Rheum 2008;59:1097-104
   PubMed Web of Science ®Google Scholar
• Fosbol EL, Gislason GH, Jacobsen S, Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study. Clin Pharmacol Ther 2009;85:190-7
   PubMed Web of Science ®Google Scholar
• Goodson NJ, Brookhart AM, Symmons DP, Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients. Rheum Dis 2009;68:367-72
   PubMed Web of Science ®Google Scholar
• van der Linden MW, van der Bij S, Welsing P, The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis 2009;68:668-73
   PubMed Web of Science ®Google Scholar
• Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993;153:477-84
   PubMed Web of Science ®Google Scholar
• Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994;121:289-300
   PubMed Web of Science ®Google Scholar
• Houston MC, Weir M, Gray J, The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil. Arch Intern Med 1995;155:1049-54
   PubMed Web of Science ®Google Scholar
• Wolfe F, Zhao S, Pettitt D. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care. J Rheumatol 2004;31:1143-51
   PubMed Web of Science ®Google Scholar
• Pavlicevic I, Kuzmanic M, Rumboldt M, Interaction between antihypertensives and NSAIDs in primary care: a controlled trial. Can J Clin Pharmacol 2008;15:e372-82
   PubMedGoogle Scholar
• Garcia Rodriguez LA, Hernandez-Diaz S. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology 2001;12:570-6
   PubMed Web of Science ®Google Scholar
• Mellemkjaer L, Blot WJ, Sorensen HT, Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol 2002;53:173-81
   PubMed Web of Science ®Google Scholar
• Richy F, Bruyere O, Ethgen O, Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach. Ann Rheum Dis 2004;63:759-66
   PubMed Web of Science ®Google Scholar
• Nielsen GL, Sorensen HT, Larsen H, Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ 2001;322:266-70
   PubMed Web of Science ®Google Scholar
• Ofori B, Oraichi D, Blais L, Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study. Birth Defects Res B Dev Reprod Toxicol 2006;77:268-79
   PubMed Web of Science ®Google Scholar
• Mulkerrin EC, Clark BA, Epstein FH. Increased salt retention and hypertension from non-steroidal agents in the elderly. QJM 1997;90:411-15
   PubMed Web of Science ®Google Scholar
• Dedier J, Stampfer MJ, Hankinson SE, Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension 2002;40:604-8
   PubMed Web of Science ®Google Scholar
• Zhao SZ, Burke TA, Whelton A, Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors. Am J Manag Care 2002;8:S401-13
   PubMed Web of Science ®Google Scholar
• Kurth T, Hennekens CH, Sturmer T, Analgesic use and risk of subsequent hypertension in apparently healthy men. Arch Intern Med 2005;165:1903-9
   PubMed Web of Science ®Google Scholar
• Sowers JR, White WB, Pitt B, The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. Arch Intern Med 2005;165:161-8
   PubMed Web of Science ®Google Scholar
• Whelton A, Lefkowith JL, West CR, Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen. Kidney Int 2006;70:1495-502
   PubMed Web of Science ®Google Scholar
• Schwartz JI, Thach C, Lasseter KC, Effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs on urinary sodium excretion, blood pressure, and other renal function indicators in elderly subjects consuming a controlled sodium diet. J Clin Pharmacol 2007;47:1521-31
   PubMed Web of Science ®Google Scholar
• Heerdink ER, Leufkens HG, Herings RM, NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 1998;158:1108-12
   PubMed Web of Science ®Google Scholar
• Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med 2000;160:777-84
   PubMed Web of Science ®Google Scholar
• Feenstra J, Heerdink ER, Grobbee DE, Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study. Arch Intern Med 2002;162:265-70
   PubMed Web of Science ®Google Scholar
• Garcia Rodriguez LA, Hernandez-Diaz S. Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure. Epidemiology 2003;14:240-6
   PubMed Web of Science ®Google Scholar
• Huerta C, Varas-Lorenzo C, Castellsague J, Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population. Heart 2006;92:1610-15
   PubMed Web of Science ®Google Scholar
• McGettigan P, Han P, Jones L, Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases. Br J Clin Pharmacol 2008;65:927-34
   PubMed Web of Science ®Google Scholar